Event Programme
19 November - 21 November
Day 1
Pharmtech & Ingredients Official Opening Ceremony
19 November
10:30 - 11:00
Presentation Zone A, Hall 7, Pavillion 2
Ceremony
Official Opening Ceremony
Round table discussion: Total readiness for medicine labelling
Participation: free, electronic ticket based
Language: Russian
Co-organised with: Association of Russian Pharmaceutical Manufacturers (ARFP)
19 November
12:00 - 14:00
Presentation Zone A, Hall 7, Pavillion 2
The session will cover issues related to the readiness of all parties involved in distributing medicines, the efficiency of the information system for monitoring the movement of medicines, as well as the initial results of labelling and traceability of medicines included in Russia’s Seven Nosologies Programme.
Presentation Zone A, Hall 7, Pavillion 2 Europe/Moscow
Round table
Total readiness for medicine labelling
The event is dedicated to the implementation of the key national project of monitoring the movement of medicines and launching universal medicine labelling from 1 January 2020.
The session will cover issues related to the readiness of all parties involved in distributing medicines, the efficiency of the information system for monitoring the movement of medicines, as well as the initial results of labelling and traceability of medicines included in Russia’s Seven Nosologies Programme.
Round table discussion: Export potential: new growth points
Participation: free, electronic ticket based
Language: Russian
Co-organised with: GMP News
19 November
15:00 - 17:00
Presentation Zone A, Hall 7, Pavillion 2
However, manufacturers find themselves in a difficult situation. While Russian medicines are in high demand in CIS countries, access to the highly competitive European market is possible only with government support and initiatives.
The round table discussion Export potential: new growth points, organised in partnership with GMP news magazine, will cover the following issues:
- Opportunities to increase the export of pharmaceutical products
- The most effective government support measures for manufacturers engaged in or planning to export
- Priority areas of integrating into the global pharmaceutical market and do Russian companies have the opportunity to occupy their niche?
Representatives of regulators, leading industry experts, and pharmaceutical companies exporting medicines will discuss case studies and will try to address the most pressing questions. Presentation Zone A, Hall 7, Pavillion 2 Europe/Moscow
Round table
Export potential: new growth points
Russian pharmaceutical manufacturers are steadily increasing their volumes of exported products. The growth is not rapid, but in general, the positive trend has been maintained for several years. According to the Federal Customs Service of Russia for the period January-May 2019, the volume of medicines exported from Russia amounted to $287.08 million USD (up 6.27% in comparison with the same period in 2018). The majority of medicines exported go to Ukraine, Kazakhstan and Belarus. According to the forecast of the Russian Federation Ministry for Industry and Trade, by 2030, the volume of medicine exports may increase 5 times. This has become one of the missions of the Pharma 2030 strategy, now under development, and the basis of the International Cooperation and Export national project. In this regard, medicine exports are becoming more and more relevant.
However, manufacturers find themselves in a difficult situation. While Russian medicines are in high demand in CIS countries, access to the highly competitive European market is possible only with government support and initiatives.
The round table discussion Export potential: new growth points, organised in partnership with GMP news magazine, will cover the following issues:
- Opportunities to increase the export of pharmaceutical products
- The most effective government support measures for manufacturers engaged in or planning to export
- Priority areas of integrating into the global pharmaceutical market and do Russian companies have the opportunity to occupy their niche?
Representatives of regulators, leading industry experts, and pharmaceutical companies exporting medicines will discuss case studies and will try to address the most pressing questions.
Seminars - November, 19
19 November
11:00 - 13:00
Prezentation Zone B, Hall 8, Pavillion 2
Seminars
Seminar by Gluvex: Engineering problems. Yesterday, today, tomorrow
Day 2
Discussion session: An effective view on technical support for medicines production
Participation: free, electronic ticket based
Language: Russian
Co-organised with: FPT
20 November
11:00 - 13:30
Presentation Zone A, Hall 7, Pavillion 2
Participants of this session will discuss the issue of efficiency at different stages of a pharmaceutical enterprise’s life cycle. Issues of effective manufacturing engineering, including capital and operating costs, operational efficiency and ways to improve it will be discussed. Special attention will be paid to innovative solutions that improve efficiency at different stages of production.
Representatives of the manufacturers of technological equipment and medicines - BWT, Marchesini, IMA, FPT – are invited. Presentation Zone A, Hall 7, Pavillion 2 Europe/Moscow
Discussion session
An effective view on technical support for medicines production
Due to the current state of the Russian economy and the decline in purchasing power of medicine users, manufacturers need to take action as soon as possible. Improving operational efficiency is becoming one of the most important tasks in the fight for profitability. Suppliers of equipment and services are also required to respond to this challenge and offer appropriate tools.
Participants of this session will discuss the issue of efficiency at different stages of a pharmaceutical enterprise’s life cycle. Issues of effective manufacturing engineering, including capital and operating costs, operational efficiency and ways to improve it will be discussed. Special attention will be paid to innovative solutions that improve efficiency at different stages of production.
Representatives of the manufacturers of technological equipment and medicines - BWT, Marchesini, IMA, FPT – are invited.
Round table discussion: API production: the economic aspect
Participation: free, electronic ticket based
Language: Russian
20 November
14:30 - 16:30
Presentation Zone A, Hall 7, Pavillion 2
How can companies producing their own substances work according to the resolution and what economic benefits they can give? These and other issues will be discussed at the round table discussion API production: the economic aspect, on 20 November at Pharmtech & Ingredients.
Speakers will include representatives of regulatory bodies, leading industry experts, and representatives of API manufacturing companies. Presentation Zone A, Hall 7, Pavillion 2 Europe/Moscow
Round table
API production: the economic aspect
Despite the decline in the supply of active pharmaceutical ingredients over recent years, financially, imports of APIs continue to grow. One of the key objectives of the Pharma 2030 programme is to provide the pharmaceutical industry with enough in terms of stock and quantity locally produced raw materials, primarily pharmaceutical substances. But there are factors that hinder the production growth of locally produced substances, the main one being the need for large investments, high material intensity and energy intensity of substance production. On the other hand, the resolution regulating public procurement of medicines, which came into force on 1 January 2019, introduced a new type of state support — a price preference of 25% of the minimum contract price. It will apply only to those companies that produce medicines in Russia and the EAEU countries on a full cycle, from the synthesis of the substance to packaging.
How can companies producing their own substances work according to the resolution and what economic benefits they can give? These and other issues will be discussed at the round table discussion API production: the economic aspect, on 20 November at Pharmtech & Ingredients.
Speakers will include representatives of regulatory bodies, leading industry experts, and representatives of API manufacturing companies.
Seminars - November, 20
20 November
11:00 - 12:00
Prezentation Zone B, Hall 8, Pavillion 2
Seminars
Seminar by Asahi Kasei Bioprocess Europe: PLANOVA Virus Removal Filters
20 November
12:10 - 14:10
Prezentation Zone B, Hall 8, Pavillion 2
Seminars
Seminar by GEA: Centrifuges and package units from GEA for human and veterinary vaccines, starter cultures production, human Blood Plasma Protein fractionation
Pharmtechprom forum - November, 20
Place: Conference Hall C, Hall 7, Pavillion 2
Participation: free, electronic ticket based
Language: Russian
20 November
10:00 - 13:30
Session A – Raw materials and pharmaceutical ingredients. Moderator: Sergey Skvortsov, Elementoorganika (Russia), Managing Director
20 November
10:30 - 11:00
Conference Hall C, Hall 7, Pavillion 2
Session A – Raw materials and pharmaceutical ingredients
Liquid and soft drugs formulation development with Super Refined excipients, eliminating instability and impurities issues
Speakers
Olesya Vereschagina
20 November
11:05 - 11:35
Conference Hall C, Hall 7, Pavillion 2
Session A – Raw materials and pharmaceutical ingredients
Pharmaceutical ingredients: optimization of production from press to coater
Speakers
Alexandra Voskoboynikova
20 November
11:40 - 12:10
Conference Hall C, Hall 7, Pavillion 2
Session A – Raw materials and pharmaceutical ingredients
Development of mucoadhesive drug delivery systems with Carbopols
Speakers
Engin Sari
20 November
12:15 - 12:45
Conference Hall C, Hall 7, Pavillion 2
Session A – Raw materials and pharmaceutical ingredients
Formulators’ tools to meet the requirements of contemporary drugs development
Speakers
Renat Kashapov
20 November
12:50 - 13:20
Conference Hall C, Hall 7, Pavillion 2
Session A – Raw materials and pharmaceutical ingredients
Digital assistant for formulation development
Speakers
Nadezhda Romanova
20 November
14:00 - 17:00
Session B – Technologies and equipment for pharmaceutical production. N. Pyatigorskaya, I.M. Sechenov First Moscow State Medical University, Head of Chair of Industrial Pharmacy, Pharm. D., Prof.
20 November
14:00 - 14:30
Conference Hall C, Hall 7, Pavillion 2
Session B – Technologies and equipment for pharmaceutical production
Isolators for Chemical and Pharmaceuticals application: Process Equipment integration into HPAPI’s containment system
Today the request of handling toxic compound in safe way is becoming more and more actual. From Charging reactors and preparation vessels to final packaging/filling operations the attention to operator safety and product protection has to be taken in consideration by using the right technology. Using rigid Isolators in most of the case is the only available solution to achieve both operator safety by process containment and product protection. The presentation is giving right indication in order to be able to select the proper containment system in function of the real necessity. Some case studies are also presented to show the state of the art and latest innovation in this field.
Speakers
Stefano Butti
20 November
14:35 - 15:05
Conference Hall C, Hall 7, Pavillion 2
Which technical solutions are needed to meet these trends and to process liquid containers in an adequate and secure way?
Let´s have a deeper look on:
- High speed processing
- In-Line inspection
- 100% In Process control
- Flexibiltiy of filling systems
- Minimizing of product loss
Session B – Technologies and equipment for pharmaceutical production
Gentle processing of ampoules and vials: One machine fits all
Which general and upcoming trends are influencing sterile ampoule and vial filling and processing?
Which technical solutions are needed to meet these trends and to process liquid containers in an adequate and secure way?
Let´s have a deeper look on:
- High speed processing
- In-Line inspection
- 100% In Process control
- Flexibiltiy of filling systems
- Minimizing of product loss
Speakers
Tobias Göttler
20 November
15:10 - 15:40
Conference Hall C, Hall 7, Pavillion 2
Müller handling equipment figures:
– Stable, lightweight and durable
– Capacity: from 0,1 L to 2000 L
- Diameter: from 80 mm to 1200 mm
– Lidded drums and drums with bungs, cylindrical and conical
– Polished surfaces for optimum product discharge
– GMP pharmaceutical standard
– Modular design
The presentation will give the different types of containers for storage and transportation of liquids and powders offered by Müller, their characteristics and advantages of use. Conference Hall C, Hall 7, Pavillion 2 Europe/Moscow
Session B – Technologies and equipment for pharmaceutical production
Handling from Powder and Liquid in the Pharmacy
Mueller Systems is a leading manufacturer of stainless-steel containers, stainless steel drums and handling equipment, offering innovative solutions and the highest quality standards. Alongside perfecting stainless-steel drums, hoppers, silos and special stainless-steel containers together with stationary and mobile handling equipment for technical processing applications in various industrial areas. MCS cleaning systems are characterized by a definable cleaning and drying process.
Müller handling equipment figures:
– Stable, lightweight and durable
– Capacity: from 0,1 L to 2000 L
- Diameter: from 80 mm to 1200 mm
– Lidded drums and drums with bungs, cylindrical and conical
– Polished surfaces for optimum product discharge
– GMP pharmaceutical standard
– Modular design
The presentation will give the different types of containers for storage and transportation of liquids and powders offered by Müller, their characteristics and advantages of use.
Speakers
Jakob Jenner
20 November
15:45 - 16:15
Conference Hall C, Hall 7, Pavillion 2
To date, the generation of large numbers of hMSCs is typically achieved using two dimensional (2D) tissue culture vessels. However, this culturing approach requires a high level of operator manipulation and offers little in the way of culture control. A possible solution is the scale-up and large-scale production of hMSCs in three dimension (3D) culture on microcarriers utilizing stirred tank bioreactors. Here we demonstrate the utility of the ambr15 and ambr250 modular stirred tank bioreactor systems as valuable tools for hMSC process development and optimization paving the way for the large-scale production of clinically relevant numbers of hMSCs. Conference Hall C, Hall 7, Pavillion 2 Europe/Moscow
Session B – Technologies and equipment for pharmaceutical production
Suspension adaptation and process development of Multipotent Mesenchymal Stem Cells for cell therapy applications
Human mesenchymal stem cells (hMSCs) have great potential as cellular therapeutics due to their ability to differentiate towards multiple lineages. Possible applications range from the treatment of Crohn’s disease to graft versus host disease and also target cardiovascular conditions among others.
To date, the generation of large numbers of hMSCs is typically achieved using two dimensional (2D) tissue culture vessels. However, this culturing approach requires a high level of operator manipulation and offers little in the way of culture control. A possible solution is the scale-up and large-scale production of hMSCs in three dimension (3D) culture on microcarriers utilizing stirred tank bioreactors. Here we demonstrate the utility of the ambr15 and ambr250 modular stirred tank bioreactor systems as valuable tools for hMSC process development and optimization paving the way for the large-scale production of clinically relevant numbers of hMSCs.
Speakers
Quentin Vicard
Day 3
Seminars - November, 21
21 November
10:30 - 11:30
Prezentation Zone B, Hall 8, Pavillion 2
Seminars
Seminar by Alfa Lab: New criterias of protective clothing selection
21 November
11:40 - 12:40
Prezentation Zone B, Hall 8, Pavillion 2
Seminars
Seminar by Alfa Lab: Advanced cleaning solutions with deconex® for the biotech production
Pharmtechprom forum - November, 21
Place: Conference Hall C, Hall 7, Pavillion 2
Participation: free, electronic ticket based
Language: Russian
21 November
10:00 - 13:30
Session C – Packaging equipment and materials. Moderator: Vladimir Stolypin, Erecton (Russia), Production Director, Ph.D.
21 November
14:00 - 17:00
Session D – Auxiliary processes in pharmaceutical production
Support and Sponsors
Sponsor of registration area
Lanyard Sponsor
Official support
Official support
General information partner
Strategic Partner
Information support
Information support
Information support
Information support
Information support
Information support
Information support
Information support
Information support
Information support
Information support
Information support
Information support
Information support
